Medical and Dental Consultantsí Association of Nigeria
Home - About us - Editorial board - Search - Ahead of print - Current issue - Archives - Submit article - Instructions - Subscribe - Advertise - Contacts - Login 
  Users Online: 1761   Home Print this page Email this page Small font sizeDefault font sizeIncrease font size
 
ARTICLE
Year : 2009  |  Volume : 12  |  Issue : 4  |  Page : 429-433

One year clinical audit of the use of blood and blood components at a tertiary hospital in Nigeria


Department of Haematology and Immunology, College of Health Sciences, Niger Delta University, Nigeria

Correspondence Address:
O P Arewa
Department of Haematology and Immunology, College of Health Sciences, Niger Delta University, Nigeria

Login to access the Email id

Source of Support: None, Conflict of Interest: None


PMID: 20329686

Rights and PermissionsRights and Permissions

BACKGROUND: The appropriate use of blood and blood components remains a formidable challenge faced by clinicians particularly in a developing country like Nigeria. The inadequate supply of safe blood implies that measures aimed at ensuring judicious use of the available supply should be continually identified and explored. STUDY DESIGN: Aprospective study to evaluate all blood and blood component transfusions over a period of one year from January to December 2004 was done. The appropriateness of the transfusion with respect to the clinical state and the transfusion needs of the recipient was assessed by a Haematologist. RESULTS: A total of 682 transfusion episodes were reviewed and analyzed. The commonest indication for use blood/blood component was severe anaemia in 38% of cases. Twenty nine percent of transfusions for moderate anemia, and 36% of fresh frozen plasma transfusions were found to be unnecessary. Inappropriate transfusion is most marked in the setting ofplatelet transfusion with 81% of platelet transfusion being inappropriate. CONCLUSION: Enhanced capacity for component preparation, regular auditing of transfusion practices as well as improved communication between the clinicians and laboratory physicians will lead to more judicious use of blood component therapy. The need for the development of guidelines for blood component use in hospitals in line with the national blood transfusion policy is highlighted.


[PDF Not available]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed590    
    Printed50    
    Emailed1    
    PDF Downloaded0    
    Comments [Add]    
    Cited by others 2    

Recommend this journal